Zied Ferjaoui

Dr. Zied Ferjaoui

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
EDEnaam Jamal Al Dine
Enaam Jamal Al Dine
AKAigul Kulmukhamedova
Aigul Kulmukhamedova
LBLina Bezdetnaya
Lina Bezdetnaya
CCCrosby Soon Chang
Crosby Soon Chang
HAHalima Alem
Halima Alem

8 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
JLJose Roberto López
Jose Roberto López
SASoheil Akbari
Soheil Akbari
FCFatiha Chandad
Fatiha Chandad
DMDiego Mantovani
Diego Mantovani
RFRoberto D. Fanganiello
Roberto D. Fanganiello
Alginate/gelatin (Alg-Gel) hydrogels have been used experimentally, associated with mesenchymal stromal/stem cells (MSCs), to guide bone tissue formation. One of the main challenges for clinical application is optimizing Alg-Gel stiffness to guide osteogenesis. In this study, we investigated how Alg-Gel stiffness could modulate the dental pulp stem cell (DPSC) attachment, morphology, proliferation, and osteogenic differentiation, identifying the optimal conditions to uncouple osteogenesis from the other cell behaviors. An array of Alg-Gel hydrogels was prepared by casting different percentages of alginate and gelatin cross-linked with 2% CaCl2. We have selected two hydrogels: one with a stiffness of 11 ± 1 kPa, referred to as “low-stiffness hydrogel”, formed by 2% alginate and 8% gelatin, and the other with a stiffness of 55 ± 3 kPa, referred to as “high-stiffness hydrogel”, formed by 8% alginate and 12% gelatin. Hydrogel analyses showed that the average swelling rates were 20 ± 3% for the low-stiffness hydrogels and 35 ± 2% for the high-stiffness hydrogels. The degradation percentage was 47 ± 5% and 18 ± 2% for the low- and high-stiffness hydrogels, respectively. Both hydrogel types showed homogeneous surface shape and protein (Alg-Gel) interaction with CaCl2 as assessed by physicochemical characterization. Cell culture showed good adhesion of the DPSCs to the hydrogels and proliferation. Furthermore, better osteogenic activity, determined by ALP activity and ARS staining, was obtained with high-stiffness hydrogels (8% alginate and 12% gelatin). In summary, this study confirms the possibility of characterizing and optimizing the stiffness of Alg-Gel gel to guide osteogenesis in vitro without altering the other cellular properties of DPSCs.

1 November 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
EDEnaam Jamal Al Dine
Enaam Jamal Al Dine
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
JGJaafar Ghanbaja
Jaafar Ghanbaja
TRThibault Roques-Carmes
Thibault Roques-Carmes
AMAbdelaziz Meftah
Abdelaziz Meftah
HAHalima Alem
Halima Alem

24 May 2024 in Advanced Engineering Materials
Verified
Journal Article
Open access
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
JLJose Roberto López
Jose Roberto López
SASoheil Akbari
Soheil Akbari
HIHawraa Issa
Hawraa Issa
ASAbdelhabib Semlali
Abdelhabib Semlali
RFRoberto Fanganiello
Roberto Fanganiello
Bone tissue engineering relies on crucial scaffolds for tissue formation and stem cell differentiation. A composite scaffold of alginate‐gelatin effectively supports these processes. This study aims to design a porous alginate‐gelatin hydrogel and assess pore size effects on cell behavior, focusing on morphology, adhesion, and proliferation in distinct osteogenic environments. Hydrogels are prepared using various alginate‐gelatin concentrations: 4% alginate and 6% gelatin (4A6G) or 3% alginate and 5% gelatin (3A5G), cross‐linked with 2% CaCl2. Pore size optimization employs simple freezing and thawing cycles. Scanning electron microscopy reveals varying pore sizes: 340 µm ± 30 µm for 4A6G and 635 µm ± 25 µm for 3A5G. Stiffness measurements indicate significant differences: ≈26.3 kPa ± 0.6 KPa for 4A6G and 21.6 kPa ± 0.2 KPa for 3A5G. Cell interaction studies demonstrate higher adhesion and proliferation rates in larger‐pored hydrogels. Evaluation of bone tissue formation, including RT‐PCR, ALP activity, and ARS staining, reveal superior osteogenic potential in the 3A5G hydrogel compared to 4A6G. In conclusion, the 3A5G hydrogel (3% alginate and 5% gelatin) holds promise for bone tissue regeneration due to its biodegradability and favorable bone‐forming properties.

17 May 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
Raphaël SchneiderRaphaël Schneider
Raphaël Schneider
AMAbdelaziz Meftah
Abdelaziz Meftah
Eric GAFFETEric GAFFET
Eric GAFFET
HAHalima Alem
Halima Alem
The preparation of responsive superparamagnetic iron oxide (SPIO) nanoparticles (NPs), able to carry the anticancer drug doxorubicin (DOX) and to release it in physiological media at the physiological temperature, is one of the major challenges in nanomedicine. In this work, two families of NPs were synthesized. The first one consists of superparamagnetic Fe3O4 NPs functionalized via covalent grafting by a biocompatible responsive copolymer based on 2-(2-methoxy)ethyl methacrylate (MEO2MA) and oligo(ethylene glycol) methacrylate (OEGMA). The second one consists of the same core/shell NPs but folic acid, a biological cancer targeting molecule, was grafted at the polymer chain end. The core/shell NPs were fully characterized by the combination of spectroscopic and microscopic techniques. The influence of the polymer chain structure in water and in physiological media was studied. We demonstrate that the magnetic properties of the NPs were only influenced by the amount of the grafted polymer and no influence of NP aggregation was evidenced. Indeed, the derived nanostructured materials displayed a combination of the physical properties of the core and the macromolecular behavior of the shell. The drug release experiments confirmed that DOX was largely released above the co-polymer LCST due to the presence of DOX. The nanomaterials developed in this work have high potential as multi-modal cancer therapy tools.

3 March 2020 in ACS Omega
Verified
Journal Article
Open access
Zied FerjaouiZied Ferjaoui
Zied Ferjaoui
SNSara Nahle
Sara Nahle
CCCrosby Soon Chang
Crosby Soon Chang
JGJaafar Ghanbaja
Jaafar Ghanbaja
OJOlivier Joubert
Olivier Joubert
HAHalima Alem
Halima Alem
Designing and manufacturing multifunctional nanoparticles (NPs) are of considerable interest for both academic and industrial research. Among NPs used in this field, iron oxide NPs show low toxicity compared to metallic ones and are thus of high interest for biomedical applications. In this work, superparamagnetic Fe3−δO4-based core/shell NPs were successfully prepared and characterized by the combination of different techniques, and their physical properties were investigated. We demonstrate the efficiency of the layer-by-layer process to graft polyelectrolytes on the surface of iron oxide NPs. The influence of the polyelectrolyte chain configuration on the magnetic properties of the Fe3−δO4/polymer core/shell NPs was enlightened. The simple and fast process described in this work is efficient for the grafting of polyelectrolytes from surfaces, and thus, derived Fe3−δO4 NPs display both the physical properties of the core and of the macromolecular shell. Finally, the cytotoxicity toward the human THP-1 monocytic cell line of the core/shell NPs was assessed. The results showed that the polymer-capped Fe3−δO4 NPs exhibited almost no toxicity after 24 h of exposure at concentrations up to 25 μg mL–1. Our results show that these smart superparamagnetic nanocarriers with stealth properties are promising for applications in multimodal cancer therapy, including drug delivery.